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Accumbens dopamine D2 receptors increase
motivation by decreasing inhibitory transmission to
the ventral pallidum
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Dopamine D2 receptors (D2Rs) in the nucleus accumbens (NAc) regulate motivated
behavior, but the underlying neurobiological mechanisms remain unresolved. Here, we show
that selective upregulation of D2Rs in the indirect pathway of the adult NAc enhances the
willingness to work for food. Mechanistic studies in brain slices reveal that D2R upregulation
attenuates inhibitory transmission at two main output projections of the indirect pathway, the
classical long-range projections to the ventral pallidum (VP), as well as local collaterals to
direct pathway medium spiny neurons. In vivo physiology confirms the reduction in indirect
pathway inhibitory transmission to the VP, and inhibition of indirect pathway terminals to VP
is sufficient to enhance motivation. In contrast, D2R upregulation in the indirect pathway does
not disinhibit neuronal activity of the direct pathway in vivo. These data suggest that D2Rs in
ventral striatal projection neurons promote motivation by weakening the canonical output to
the ventral pallidum.
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Motivational abnormalities are observed in psychiatricdisorders including depression, schizophrenia,attention-deficit hyperactivity disorder (ADHD) and
substance abuse. A core deficit of these disorders, motivational
dysfunction is disruptive to everyday life and in many cases
cannot be treated1,2.
The nucleus accumbens (NAc) and its dopaminergic innerva-
tion are particularly critical for motivated behavior, and phar-
macological studies implicate striatal dopamine receptors in the
regulation of incentive motivation3,4. Antagonists for D1-like and
D2-like receptors delivered to the NAc decrease the willingness to
work for rewards5. Rather than affecting the hedonic value of the
reward, it has been suggested that NAc dopamine promotes
behavioral activation by regulating effort-related processes and
overcoming work-related response costs3,6–8. In line with these
observations in animal models, abnormalities in striatal D2
receptor (D2R) levels have been consistently observed in human
disorders with altered motivation including addiction, schizo-
phrenia and ADHD9–16. Moreover, higher D2R binding in left
striatum relative to the right striatum has been associated with
higher incentive motivation17.
In a recent behavioral study, we demonstrated that over-
expression of postsynaptic D2Rs in the mouse NAc increased
motivation without altering consummatory behavior, the repre-
sentation of the value of the reinforcer, or the ability to flexibly
use reward-associated cues18. Yet, the cellular and neurophysio-
logical mechanisms by which dopamine D2Rs regulate motivated
behavior remain unclear. A critical barrier in the study of D2R
function in the NAc has been that D2Rs are expressed in multiple
cell types including medium spiny neurons (MSNs), cholinergic
interneurons (CINs), as well as on terminals of dopaminergic
neurons. Therefore, strategies that enable selective manipulation
of D2Rs in relevant cell populations are uniquely suited to
identifying cell-specific roles of D2Rs in motivation and to
interrogate the consequences of D2R function on basal ganglia
circuitry underlying motivated behavior. For this purpose, we
recently developed an adeno-associated virus (AAV)-based
approach that, in contrast to our initial study18, allows selective
overexpression of D2Rs in the striatal output pathway of the adult
NAc core that endogenously express D2Rs, the indirect pathway
(D2R-OENAcInd mice)19.
The indirect pathway is one of the two main output pathways
of the striatum. The indirect pathway expresses D2Rs and mod-
ulates the internal segment of the globus pallidus (GPi) and the
substantia nigra pars reticulata (SNr) output nuclei through a
polysynaptic circuit via the external segment of the GP (GPe)20.
In contrast, the direct pathway predominantly expresses D1Rs
and not D2Rs. It projects monosynaptically to the basal ganglia
output nuclei of the GPi and the SNr, but also innervates the
“indirect” GPe via bridging collaterals21,22. The direct and
indirect pathways exert opposing effects on thalamo-cortical
activation and are therefore often referred to as “Go” and “NoGo”
pathway, respectively. This opposing function has been histori-
cally studied in the context of motor regulation and Parkinson’s
disease23. Within the dorsomedial striatum, artificial stimulation
of the direct pathway promotes locomotion, whereas activation of
the indirect pathway inhibits locomotion8,22,24. Nevertheless,
both pathways are activated during movement initiation25.
Within the ventral striatum, analogous direct and indirect
pathways have also been described26–28. Like dorsal striatal D2R-
expressing MSNs (D2-MSNs) that innervate the GPe, NAc D2-
MSNs project to the ventral pallidum (VP). However, recent work
suggests that the ventral striatal output pathways are less segre-
gated than those of the dorsal striatum since ventral striatal D1-
expressing MSNs (D1-MSNs) of the “direct” pathway robustly
innervate the VP, in contrast to the less extensive innervation of
the GPe by dorsal striatal D1-MSNs29. Despite this relative dif-
ference in architecture, opposing functions of D1R versus D2R-
expressing ventral striatal pathways have been described. For
example, while NAc D1-MSNs have been shown to promote
psychostimulant sensitization, conditioned place preference, and
self-administration, D2-MSNs of the indirect pathway generally
inhibit these behaviors30–33. Thus, we also refer to D1-MSNs and
D2-MSNs in the NAc as direct pathway and indirect pathway
neurons, respectively.
In dopamine neurons, presynaptic D2-autoreceptors are
thought to inhibit dopamine release via Gβγ-mediated inhibition
of voltage-gated calcium channels and activation of Kv1.2
potassium channels34–36. Likewise, slice physiology studies have
shown that pharmacological activation of D2Rs reduces inhibi-
tory transmission at the two main outputs of the indirect path-
way, intra-striatal collaterals and striatopallidal synapses37–40.
Here, we find that selective upregulation of D2Rs in the
indirect pathway of the NAc enhances the willingness to work for
food in a progressive ratio (PR) task. Using in vitro slice
recordings, we find that this increase in motivation is associated
with decreased inhibitory transmission from D2-MSNs, resulting
in decreased collateral inhibition of direct pathway MSNs within
the NAc and in blunted indirect pathway output from the NAc to
the VP. However, despite a pronounced decrease in collateral
inhibition in the slice after D2-MSN stimulation, D1-MSNs are
not more active during the PR task than in control mice, sug-
gesting that collateral inhibition during the PR task may not be
strong enough to influence direct pathway activity. In contrast,
in vivo recordings of VP activity following cortical stimulation
reveals a decrease in VP inhibition upon D2R upregulation.
Moreover, using pathway-specific expression of a designer
receptor in vivo, we show that inhibition of synaptic transmission
from the indirect pathway to the VP is sufficient to enhance
motivated behavior. These findings suggest that D2Rs in NAc D2-
MSNs regulate motivated behavior by disinhibiting the ventral
pallidum.
Results
D2R upregulation in NAc D2-MSNs increases motivation. We
selectively targeted NAc D2-MSNs by bilaterally injecting Cre-
dependent adeno-associated viruses (AAVs) expressing either
D2R-IRES-mVenus or EGFP into the NAc core of Drd2-Cre
mice. We previously demonstrated that this strategy results in a
three-fold increase in D2R radioligand binding in NAc mem-
branes19. Upregulation was essentially restricted to D2-MSNs,
with very limited transgene expression in cholinergic inter-
neurons (1 out of 20 ChAT+ neurons)19. We further observed
that viral-mediated D2R expression was specific to the indirect
projection pathway, as mVenus or D2R immunoreactive term-
inals were observed exclusively in the projection target of NAc
D2-MSNs, the VP, but not in the substantia nigra pars reticulata
(Fig. 1a).
To assess the effect of D2R upregulation on the willingness of
mice to work for a food reward, we used a progressive ratio (PR)
task, in which the lever press requirement doubled with each
successive reward earned. Mice expressing EGFP (EGFPNAcInd) or
overexpressing D2R (D2R-OENAcInd) in D2-MSNs underwent
operant training 4 weeks after surgery using a continuous
reinforcement (CRF) schedule, followed by fixed interval (FI)
training prior to PR testing. The groups did not differ in
performance on either CRF (t= 0.68, p= 0.51) or on any FI
schedule tested (Fig. 1b, all ps > 0.05), suggesting that D2R
upregulation does not impact operant training.
In the PR task, a survival analysis of the percentage of mice that
continue to respond as a function of time revealed that, compared
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to EGFPNAcInd controls, D2R-OENAcInd mice responded for a
significantly longer time (χ2= 4.631, p < 0.05, Log-rank test;
Fig. 1c, d). Moreover, D2R-OENAcInd mice showed significantly
increased lever pressing (t= 2.309, p < 0.05, n= 7–8/group) and a
higher breakpoint (t= 2.188, p < 0.05, n= 7–8/group; Fig. 1e, f).
In contrast, the press rate was not altered in D2R-OENAcInd mice
(Fig. 1g).
To determine whether the small subset of cholinergic
interneurons that overexpress D2Rs in the Drd2-Cre line might
contribute to these effects19, we used the same approach using








































































































































Fig. 1 D2R upregulation enhances motivated behavior. a (Left) Sagittal image of a Drd2-Cre mouse showing that virus-mediated expression (mVenus) is
largely restricted to neurons in the NAc core. mVenus-positive terminal fields are observed in the VP, but not the SNr. Scale= 500 µm. (Middle) Higher
magnification image shows increased D2R immunolabeling in the NAc core and in the VP. Scale= 250 µm. (Right) Coronal view of viral D2R-positive
terminal fields in the dorsolateral VP (dlVP). Scale= 150 µm. b D2R overexpression did not alter operant learning on continuous reinforcement (CRF)
schedules or performance on fixed interval (FI) schedules conducted prior to progressive ratio (PR) testing. c Kaplan–Meier survival function showing the
percentage of mice that continues to respond on the PR schedule as a function of session time. D2R-OENAcInd mice continue to respond significantly longer
than control EGFPNAcInd mice. Average data of three different PR sessions are shown (n= 7 or 8 mice/group). d Total session duration was significantly
increased for D2R-OENAcInd mice. e, f D2R-OENAcInd exhibit significantly increased lever presses and a higher breakpoint compared to controls. g Press rate,
plotted here as a function of the ratio requirement, was unaltered. h In a random ratio (RR) schedule without concurrent food presentation (NO CHOICE),
D2R-OENAcInd mice showed significantly higher lever-pressing than controls (n= 7 mice/group). i When a freely-available, standard chow was
simultaneously presented (CHOICE), D2R-OENAcInd mice continued to press significantly more than controls. Error bars= s.e.m.
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interneurons did not alter PR performance (Supplementary
Fig. 1). These results indicate that D2R upregulation in indirect
pathway projection neurons of the NAc core is sufficient to
enhance the willingness to work for a reward.
We also evaluated the impact of D2R upregulation on effort-
related decision-making using a concurrent choice task3,18. This
paradigm measures the animals’ choice to work for a preferred
reward (evaporated milk) when simultaneously presented with a
less preferred but freely accessible reward (chow). When no chow
was available (“no choice”), D2R-OENAcInd mice exhibited an
overall increase in responding to the increasing ratio require-
ments compared to controls (F(1,12)= 8.792, p < 0.05) (Fig. 1h).
There was also an interaction of D2R upregulation with work
requirement (F(5,60)= 3.179, p < 0.05). This effect was particularly
prominent at the highest ratio requirements RR80 and RR120
(Bonferroni post hoc test, p < 0.01), where D2R upregulation led
to higher responding compared to EGFP. As expected, when
chow was freely available in the operant chamber (“choice”), both
groups showed a reduction in responding compared to the “no-
choice” setting, especially at the more demanding ratio require-
ments (Fig. 1i). A 2-way ANOVA further indicates that, in the
presence of chow, D2R-OENAcInd mice exhibited higher respond-
ing compared to EGFPNAcInd mice (virus effect: F(1,12)= 8.851, p
< 0.05; virus × ratio interaction: (F(5,60)= 3.302, p < 0.05).
EGFPNAcInd mice reduced their responding sooner than the
D2R-OENAcInd mice and the performance difference between the
two groups was measurable at a lower ratio when free food was
available (RR40, Bonferroni post hoc test: p < 0.05) compared to
RR80 in the “no-choice” setting. Together with the PR data, these
results suggest that increased D2R levels in accumbal indirect
pathway MSNs promote incentive motivation.
D2R upregulation in D2-MSNs reduces inhibition of D1-
MSNs. To identify neuronal mechanisms by which D2R upre-
gulation enhances motivation we turned to whole cell patch
clamp recordings in NAc slices. Due to the proposed role of
presynaptic D2Rs in regulating transmitter release, we examined
whether D2R upregulation affects the functional output of D2-
MSNs. D2-MSNs extend local inhibitory axon collaterals to D1-
MSNs of the direct pathway38,40–44. To determine the impact of
D2R upregulation on D2-to-D1-MSN collateral transmission, we
co-expressed channelrhodopsin-2 (ChR2) and D2R or EGFP in
D2-MSNs. About 84% of ChR2 positive neurons co-expressed
D2R-IRES-Venus, and we confirmed that the ability to induce
action potentials by ChR2 activation in D2-MSNs was similar
between groups (Supplementary Figs. 2 and 3). Optically-evoked
inhibitory postsynaptic currents (oIPSCs) were recorded from the
non-fluorescent, D1-MSN-enriched MSN population following
photostimulation of D2-MSNs (Fig. 2a). In both groups of ani-
mals, we measured oIPSCs that were blocked by the GABAA
receptor antagonist bicuculline (10 µM) (Fig. 2b). Notably, we
found that the peak amplitude of the oIPSCs was dramatically
attenuated in D1-MSNs of D2R-OENAcInd mice compared to
EGFP controls (51.1 ± 10.9 vs. 273.1 ± 51.6 pA; t= 4.709, p <
0.0001, n= EGFP: 11(6), D2: 14(9) cells/group) (Fig. 2b, c).
Moreover, while the D2R agonist quinpirole (1 µM) attenuated
the oIPSC in over 90% of recorded neurons in both EGFPNAcInd
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Fig. 2 D2R upregulation in D2-MSNs leads to reduced local collateral transmission. a Inhibitory postsynaptic currents (IPSCs) were evoked by blue light
illumination of MSNs co-expressing ChR2 and D2R or ChR2 and EGFP in NAc slices. oIPSCs were recorded from neighboring non-fluorescent MSNs. b
Individual (gray) and average (black) traces oIPSC traces (gray) from representative MSNs following five 50-ms light pulses (1 Hz). Bicuculline (10 µM)
eliminated the oIPSC. c Peak oIPSC amplitude under basal conditions was significantly reduced when D2Rs were overexpressed in D2-MSNs [n= 11 cells
(6 mice) or 14 cells (9 mice)]. d, e Treatment with quinpirole (1 µM) reduced oIPSC amplitude in both groups, though to a greater extent in D2R-OE mice
[n= 10 cells (6 mice) or 14 cells (9 mice)]. f Quinpirole showed an inhibitory effect on oIPSC amplitude in >90% of cells recorded in both groups. g
Sulpiride co-treatment (1 µM) reversed the effect of quinpirole on peak oIPSC amplitude [n= 7 cells (4 mice) or 11 cells (8 mice)]. Error bars= s.e.m.
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inhibition was much greater in the D2R-OENAcInd mice (85.4 ±
6.8 % vs. 37.1 ± 6.1 % in EGFP controls; t= 5.105, p < 0.0001)
(Fig. 2d–f). When the D2R antagonist sulpiride (1 µM) was co-
applied with quinpirole in a subset of cells that had been treated
with quinpirole alone, the oIPSC amplitude was reversed to near
basal levels in both groups (Fig. 2g). Together, these results
suggest that D2R upregulation in D2-MSNs reduces collateral
inhibition of D1-MSNs.
The enhanced quinpirole-mediated effect on oIPSC size
observed in D2R-OENAcInd mice is consistent with enhanced
presynaptic inhibition of GABA release mediated by activation of
a greater number of presynaptic D2Rs. However, it remains
unclear whether pre- or postsynaptic mechanisms are responsible
for the basal reduction in oIPSC amplitude in D1-MSNs of these
mice. D1-MSN intrinsic membrane properties and excitability
were not altered in D2R-OENAcInd mice (Supplementary Fig. 4).
In addition, analysis of miniature inhibitory postsynaptic currents
(mIPSCs) in D1-MSNs revealed no significant effects of D2R
upregulation on either mIPSC frequency or amplitude (Supple-
mentary Fig. 5). However, in the slice preparation, inhibitory
events onto MSNs are derived, to a great extent, from striatal
interneurons45, so these measurements may not be sufficiently
sensitive to detect changes in the collateral inputs from indirect
pathway neurons.
Therefore, to achieve greater input-specificity, we replaced
extracellular Ca2+ with strontium (Sr2+) and recorded from D1-
MSNs following optogenetic stimulation of D2-MSNs (Supple-
mentary Fig. 6). Under these conditions, Sr2+ leads to
desynchronization of neurotransmitter release in terminals
recently invaded by an action potential, generating asynchronous
IPSCs (asIPSCs) that can be measured for several hundred
milliseconds after the initial stimulus46. This technique has been
used to directly assess postsynaptic efficacy (asIPSC amplitude)
and, indirectly, presynaptic function or number of synaptic
contacts (asIPSC frequency) in specific basal ganglia circuits46–48.
We found that in this paradigm, D2R upregulation resulted in
significantly decreased mean asIPSC amplitude and frequency
even after normalization to the amplitude of the oIPSC
(Supplementary Fig. 6). Together, these data suggest that the
basal decrease in inhibitory transmission observed in D2R-
OENacInd mice is due both to pre- and postsynaptic alterations,
without associated changes in excitability or global inhibitory
input.
In vivo D1-MSN activity is not altered by D2R upregulation.
We hypothesized that reduced collateral inhibition onto D1-
MSNs might enhance direct pathway activity and thereby con-
tribute to the increase in motivation. To this end, we expressed
either DIO-D2R-ires-mCherry or DIO-mCherry in NAc D2-
MSNs in Drd2-Cre mice, while simultaneously expressing the
genetically encoded Ca2+ sensor GCaMP6f in D1-MSNs using a
Cre-OFF FAS system49 (Fig. 3a). We verified that the FAS-
GCaMP6f construct was targeted to non-Cre expressing cells in
Drd2-Cre mice (Fig. 3b). A microendoscopic lens was implanted
above the viral injection site to image putative D1-MSN Ca2+
activity during the PR task (Fig. 3c).
We recorded Ca2+ activity in a 5-min period in the PR test that
encompasses the ratios with the highest press rates in both
groups. First, we determined whether D2R upregulation was
associated with changes in basal Ca2+ activity in D1-MSNs. We
used the constrained non-negative matrix factorization frame-
work modified for microendoscopes (CNMF-E) to localize
neurons and extract denoised and demixed Ca2+ signals in our
recordings50. We reliably detected low frequency, high amplitude
Ca2+ transients, as reported in other studies of Ca2+ activity in
MSNs51 (Fig. 3c–e). D2R upregulation, however, did not result in
significant changes in the average frequency of Ca2+ transients
(mCherry: 0.069 ± 0.006 Hz; D2: 0.082 ± 0.002 Hz; t= 1.97, p=
0.12, n= 3 mice/group) (Fig. 3f). Similar results were obtained
when the threshold for transient detection was increased to 2 or 3
S.D. above baseline activity (2 S.D.: mCherry: 0.032 ± 0.002 Hz;
D2: 0.035 ± 0.001 Hz; t= 1.73, p= 0.16; 3 S.D.: mCherry: 0.021 ±
0.001 Hz; D2: 0.021 ± 0.001 Hz; t= 0.383, p= 0.72; n= 3 mice/
group). In addition, we sought to determine whether changes in
Ca2+ signals were temporally associated with specific behavioral
events during PR, such as lever pressing or reward approach.
While we observed no clear relationship between Ca2+ activity
and lever pressing (not shown), our analyses revealed that head
entries into the reward port were associated with changes in Ca2+
activity, but only in a small number of D1-MSNs (Supplementary
Fig. 7). Because these event-related changes in Ca2+ signals were
not consistently observed across all rewards retrieved by one
mouse and because they showed large variability within groups,
no quantitative comparisons were drawn. Similar results were
obtained when mice were run on a different food incentive
operant task (FR5) (mCherry: 0.098 ± 0.007 Hz; D2: 0.118 ±
0.011 Hz; t= 1.405, p= 0.203, n= 4–5 mice/group) (Supplemen-
tary Fig. 8). These in vivo data suggest that D2R upregulation in
D2-MSNs does not result in increased D1-MSN activity during
the periods of highest responding in PR or in FR5.
Accumbens D2Rs reduce inhibition of ventral pallidal neurons.
D2-MSNs in the NAc core send extensive projections to the
ventral pallidum. We used an optogenetic approach similar to that
used for the intra-NAc collaterals to test whether D2R upregula-
tion in D2-MSNs reduces inhibitory transmission to the VP. We
co-expressed ChR2 with either D2R or EGFP in NAc core D2-
MSNs. Four weeks later, we recorded from VP neurons within
dense, virus-positive terminal fields in slices of the dorsolateral VP
(Fig. 4a, b), the primary target area of the NAc core27. This slice
preparation did not include NAc (or D2-MSN cell bodies),
allowing for selective light-evoked stimulation of D2-MSN term-
inals. Within the VP, we recorded oIPSCs from neurons with the
characteristics described for putative GABAergic type B neurons
in rat VP slices52,53 including spontaneous spiking, slow ramp-like
depolarization preceding short duration spikes, and prominent
afterhyperpolarization (Fig. 4c). The intrinsic properties of VP
neurons recorded from both groups were comparable (resting
membrane potential: EGFP, −46.5 ± 1.3mV, n= 11 cells; D2,
–49.8 ± 2.0, n= 13 cells; t= 1.3, p= 0.21; input resistance=
EGFP, 317.1 ± 45.3MΩ, n= 11 cells; D2, 590.7 ± 172.6, n= 13
cells; t= 1.4, p= 0.17). We found that D2R upregulation in D2-
MSNs led to an approximately 65% reduction in oIPSC amplitude
compared to controls after photostimulation of ChR2-positive D2-
MSN terminals in the VP (Fig. 4d, e; t= 2.448, p < 0.05, n=
EGFP: 13(10), D2: 11(7) cells/group). Under our stimulation
conditions, we found that quinpirole (1 µM) had a bidirectional
effect on oIPSC amplitude in control EGFPNAcInd VP cells. After
quinpirole, 55% of control VP neurons showed an attenuated
response, whereas 45% showed an enhanced oIPSC (Fig. 4f and
Supplementary Fig. 9). In contrast, quinpirole decreased oIPSC
amplitude in >90% of VP cells in D2R-OENAcInd slices. The bias
towards decreased oIPSCs in response to quinpirole in D2R-
OENAcInd VP cells suggests that additional presynaptic D2Rs play
an inhibitory role in regulating GABAergic transmission between
NAc D2-MSNs and VP. Co-treatment with sulpiride (1 µM)
reversed the oIPSC to near basal levels (Fig. 4g and Supplementary
Fig. 9). Similar effects on oIPSC amplitude under basal conditions
and following quinpirole were observed using light pulses of
shorter duration (1 ms) (Supplementary Fig. 10).
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Inhibition of pallidal activity is reduced by D2Rs in vivo. We
extended these findings from slice preparations by asking whether
D2R upregulation also affects VP inhibition in an in vivo model
in which cortico-basal ganglia loops remain intact. The medial
prefrontal cortex (mPFC) exerts both excitatory and inhibitory
regulation of VP neurons (Fig. 5a). Activation of the mPFC
excites VP neurons directly through glutamatergic projections
from the mPFC, as well as indirectly via the subthalamic
nucleus54–56. It also leads indirectly to inhibition of VP neuron
activity through its activation of NAc GABAergic projection
neurons55,57,58. We hypothesized that, by decreasing D2-MSN
output to VP, D2R upregulation in NAc D2-MSNs would
decrease the inhibitory response of VP neurons to mPFC sti-
mulation, while leaving the excitatory response unaffected
(Fig. 5b). We performed single unit recordings in the VP of
anesthetized D2R-OENAcInd and EGFPNAcInd mice during elec-
trical stimulation of mPFC (Fig. 5a, b). VP neuronal responses
were assessed using peristimulus histograms (PSTHs) for 50 sti-
mulus trials (0.2 ms pulse, 0.5 Hz) (Fig. 5c–f). To assess patterns
in PSTHs, responses were first quantified using two-sample
Kolmogorov–Smirnov (K–S) tests. While mPFC stimulation
typically induced an excitation-inhibition response in VP neurons
in EGFPNAcInd mice, VP neurons in D2R-OENAcInd mice gen-
erally lacked the inhibitory response (K–S test: 0.25 mA: Z= 1.13,
p= 0.15; 0.5 mA: Z= 1.70, p < 0.01; 0.75 mA: Z= 2.08, p < 0.01;
1.0 mA: D= 2.08, p < 0.01). VP neuronal responses were further
quantified using Z score analysis, which revealed a significant
current and genotype interaction (Fig. 5g) (EGFPNAcInd mice:
Fcurrent [1,4]= 35.2, p < 0.01; D2R-OENAcInd mice:
Fcurrent [1,4]= 15.4, p= 0.02; Fgenotype × current [1,8]= 44.34,
p < 0.01). Thus, both ex vivo and in vivo results provide
evidence for reduced indirect pathway-mediated inhibition of VP
neurons as a consequence of D2R upregulation in accumbal D2-
MSNs.
Drd2-Cre






















































































Fig. 3 D2R upregulation in D2-MSNs does not alter D1-MSN activity in vivo. a Schematic of GRIN lens lowered into the NAc core of Drd2-Cre mice
transduced with a Cre-ON D2-IRES-mCherry or mCherry in Cre (+) cells (primarily expressed in D2-MSNs) and a Cre-OFF GCaMP6f in Cre (–) cells
(primarily expressed in D1-MSNs). b Double immunofluorescence analysis against Cre and GFP shows that in a Drd2-Cre mouse, Cre-OFF GCaMP6f (cyan)
expression is restricted to Cre (–) cells. Scale= 25 μm. c Representative fluorescent image from live D1-MSNs expressing Cre-OFF GCaMP6f. d Individual
neural Ca2+ transient traces from D1-MSNs in one representative mouse during progressive ratio task. e Ca2+ transients were defined as events with peak
amplitudes greater than 1 standard deviation (S.D.) from baseline activity for analysis. Red circles denote transients whose amplitudes are above 1 S.D.
f Frequency of Ca2+ transients recorded during PR from individual cells in 3 mice per group
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Inhibiting accumbopallidal transmission enhances motivation.
Our slice electrophysiology results reported above are consistent
with an inhibitory role of D2Rs located on D2-MSN terminals in
VP. We therefore examined whether inhibition of D2-MSN
synaptic transmission to the VP represents the neuronal
mechanism by which D2R upregulation enhances motivation. We
first co-expressed the DREADD hM4Di—which like D2R is Gi/o/
z-coupled—and ChR2 in NAc D2-MSNs. We then recorded
oIPSCs in VP slices containing virus-positive D2-MSN terminals
in the presence or absence of CNO (Fig. 6a). Similar to the
inhibitory effects of quinpirole in D2R-OENAcInd mice, light-
evoked IPSCs were significantly diminished by CNO (10 µM) in
all VP neurons recorded (t= 4.284, p < 0.005) (Fig. 6b, c), as
observed by Bock et al31. This suggests that Gi/o/z-activation in
D2-MSN terminals reduces GABAergic output onto VP neurons.
We then tested whether Gi/o/z-mediated inhibition of D2-MSN
projections innervating the VP alters PR performance. To this
end, we bilaterally expressed hM4Di-mCherry in D2-MSNs of the
NAc and implanted microinfusion bilateral cannulae targeting the
mCherry-positive terminal fields in the caudal aspect of the
dorsolateral VP (Fig. 6d, e and Supplementary Fig. 11). All mice
underwent 2 PR sessions, prior to which they received local,
bilateral microinfusions of CNO or saline (0.3 µl/side) in a
counterbalanced fashion. Survival function analysis revealed a
significant CNO effect on the percentage of mice that continued to
respond as session time elapsed (Log-rank test, χ2= 7.244, p <
0.001) (Fig. 6f). CNO also led to a significant increase in total
session duration compared to saline treatment (t= 3.54, p=
0.005, n= 16/group) (Fig. 6g). In addition, the number of presses
and the breakpoint were significantly enhanced (presses: t= 3.054,
p < 0.01; breakpoint: t= 3.128, p < 0.01, n= 16/group) (Fig. 6h, i),
while press rate was unaltered (Fig. 6j). CNO injection did not
enhance motivation in the absence of hM4D expression
(Supplementary Fig. 12). These results indicate that inhibition of
the D2-MSN projections just within the VP is sufficient to
enhance motivation.
Discussion
We have found that selective upregulation of D2Rs in the indirect
pathway of the NAc increases motivated behavior. This is asso-
ciated with decreased inhibitory transmission to two main D2-
MSN targets, neurons in the ventral pallidum and MSNs of the
direct pathway. In vivo, D2R upregulation was associated with
decreased inhibition of the VP, but not of putative D1-MSNs.
Moreover, inhibition of synaptic transmission from D2-MSNs to
the VP is sufficient to enhance motivation. Our data therefore
suggest that D2R upregulation promotes motivated behavior by
weakening the canonical indirect pathway projections to the VP.
Earlier studies using lesions or localized infusions of GABA
agonists or antagonists into the VP have shown the importance of
this region in motivated behavior59. Moreover, local injections of
the GABA agonist muscimol into the subthalamic nucleus (STN),
one synapse downstream of the VP, enhanced PR performance60.
Thus, we propose that disinhibition of the VP as achieved by D2R
upregulation in NAc D2-MSNs or by increased Gi/o signaling via
hM4Di activation in D2-MSN terminals, may invigorate PR
performance, in part, through a reduction of STN function.
Our results also implicate altered local collateral inhibition of
the direct pathway as a mechanism by which D2R upregulation
enhances motivation. Studies using paired recordings or opto-
genetic tools have shown significant functional connectivity
between MSNs in the striatum38,40–44,61. Generally, D2-MSNs
have a stronger influence on D1-MSNs than D1-MSNs on D2-
MSNs43. Here, we observed collateral inhibition from D2-MSNs
to virus-negative MSNs, which in the NAc core are enriched in
D1-MSNs of the direct pathway. This collateral inhibition was
strongly reduced in D2R-OENAcInd mice.
However, despite these findings in the slice preparation, using
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Fig. 4 D2R upregulation reduces D2-MSN inhibitory transmission to ventral pallidum (VP). a Schematic of oIPSCs recordings from VP neurons in slice
following blue-light stimulation of terminal fields from NAc MSNs co-expressing ChR2 and D2R or ChR2 and EGFP. b VP neurons were recorded from
within virus-positive NAc D2-MSN terminal fields in the dorsolateral VP (dlVP). Scale bar= 150 µm. c Target neurons in VP typically displayed
spontaneous firing activity, depolarized RMP, slow ramp-like depolarization preceding short duration spikes, and prominent afterhyperpolarization. d
Individual (gray) and average (black) oIPSC traces (gray) from representative MSNs following five 50-ms light pulses (1 Hz). Bicuculline (10 µM)
eliminated the oIPSC. e Peak oIPSC amplitude under basal conditions was significantly reduced when D2Rs were overexpressed in D2-MSNs MSNs [n= 13
cells (10 mice) or 11 cells (7 mice)]. f Quinpirole (1 µM) bidirectionally modulated oIPSCs recorded in EGFPNAcInd VP neurons MSNs [n= 11 cells (9 mice)
or 10 cells (6 mice)]. In contrast, quinpirole decreased the oIPSC amplitude in >90% of cells recorded in D2R-OENAcInd VP. g Opposite influences of D2
agonist and antagonist are highlighted by the overall effect of quinpirole and quinpirole+ sulpiride (1 µM) on oIPSC amplitude. Error bars= s.e.m.
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effect of D2R upregulation on D1-MSN activity. This suggests
that a reduction in D2-MSN-to-D1-MSN transmission is not
sufficient to alter overall activity of direct pathway neurons
during tasks of incentive motivation, thus arguing against disin-
hibition of D1-MSNs as a principal mechanism underlying the
increase in motivation seen following D2R upregulation. It is
possible that the role of D2Rs in lateral inhibition between D2
and D1-MSNs, however, is more behaviorally relevant in settings
of high dopamine release, as in the behavioral response to
psychostimulants61.
D1-MSNs of the NAc also send projections to the VP in
addition to their well-known projections to the midbrain29,
analogous to striatopallidal D1 “bridging” collaterals in the dorsal
striatum22. These projections might also play a role in regulating
motivation. However, our in vivo analysis did not identify
alterations in D1-MSN activity, suggesting that this pathway may
not be affected in D2R-OENacInd mice.
Our slice physiology results show that D2R upregulation in
D2-MSNs leads to a profound reduction in light-evoked inhibi-
tory transmission to both local and distal targets via two
mechanisms. First, we observed pre- and postsynaptic adapta-
tions that reduce the basal strength of these connections. Acute
sulpiride (D2R antagonist/inverse agonist) failed to restore the
basal oIPSC amplitude in D2R-OENAcInd mice to control levels,
arguing against ambient dopamine or constitutive activity of the

















































































































Fig. 5 D2R upregulation is associated with reduced mPFC-evoked inhibition of ventral pallidal neurons in vivo. a, b Schematic depictions of the stimulating
electrode in the medial prefrontal cortex (mPFC) and the recording electrode in the VP in anesthetized mice. mPFC stimulation can lead to excitation of VP
neurons directly or via the subthalamic nucleus (STN). mPFC stimulation also leads to inhibitory responses in VP by activation of NAc GABAergic
projection neurons. Solid green arrows and (+) sign depict excitatory projections, while the dotted red arrow and (–) sign represent inhibitory projections.
Insets, representative VP spike waveforms from recorded cells (overlay of ~500 spikes; scale= 1.0 ms, 0.1 mV) are consistent with those of GABAergic
neurons. We hypothesized that, in contrast to EGFP controls (a), additional D2Rs (pink) in NAc D2-MSNs would attenuate cortically-evoked inhibition of
VP (b). c–f Z score transformed peristimulus time histograms (PSTHs) showing mPFC-evoked responses in all recorded VP neurons at different stimulation
intensities. Electrical stimulation of the mPFC resulted in an excitation-inhibition response in the VP in the EGFPNAcInd mice. VP neurons in D2R-OENAcInd
mice generally lacked the inhibitory response. g Change in firing rate during the 75ms following mPFC stimulation expressed as a Z score of the pre-
stimulation firing rate distribution. Basal firing rates were not different between the two groups (EGFPNAcInd mice: 8.83[1.67] Hz; D2R-OENAcInd mice: 11.18
[2.08] Hz, t22=−0.83, p= 0.42). EGFPNAcInd: n= 10 (5) units, D2R-OENAcInd: n= 14 (5) units. Error bars= s.e.m.
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transmission. The strontium experiments revealed a reduction in
both the frequency and amplitude of asIPSCs that was indepen-
dent of the initial stimulus strength. These data, therefore, point
to changes both at the level of presynaptic release (or number of
synaptic contacts), and at the level of postsynaptic efficacy.
Defining the precise mechanisms underlying these synaptic
adaptations in basal D2-MSN output will be of interest for further
investigation.
Second, acute treatment with the D2R agonist quinpirole
attenuated light-evoked inhibitory currents in the NAc, an effect
that was enhanced in D2R-OENacInd mice. This enhancement is
likely due to decreased presynaptic function mediated by
increased D2R levels, consistent with reports of acute presynaptic
effects of quinpirole or dopamine on MSN-MSN or MSN-
pallidum transmission37–40,61. Application of CNO to hM4Di-
expressing D2-MSNs also resulted in acute attenuation of oIPSC
in VP neurons, similar to the inhibitory effect of quinpirole in
D2R-OENAcInd mice, suggesting that Gi/o/z coupled-signaling may
be involved in both cases.
In our experiments, light-evoked IPSCs at D2-MSN to D1-
MSN synapses were more sensitive to quinpirole-mediated inhi-
bition than at striatopallidal synapses in EGFPNAcInd mice, in
agreement with other reports61. Over 90% of D2-to-D1-MSN
oIPSCs were reduced by quinpirole whereas only 55% of stria-
topallidal oIPSCs transmission were reduced by the D2 agonist.
Surprisingly, quinpirole increased the oIPSC in 45% of VP cells.
The interpretation of the quinpirole effect is complicated by the
fact that inhibition within the pallidum is also mediated by intra-
pallidal connections of GABAergic neurons62, some of which also
express D2/D3/D4 receptors56,63–65. Indeed, in vivo studies
measuring VP firing rates after iontophoretic application of
quinpirole found that about 24% of VP neurons increased their
firing rates as expected but 15% of VP neurons decreased their
firing rates66. This bidirectional effect may be due to D2-like
receptors expressed within the VP. In D2R-OENAcInd mice, where
D2Rs are selectively increased in D2-MSNs of the NAc, the bal-
ance was altered and the oIPSC were reduced in 90% of neurons
in the presence of quinpirole. This suggests that presynaptic D2Rs
at ventral striatopallidal terminals inhibit neurotransmission, as
proposed in the GPe37,39. Besides showing enhanced quinpirole-
mediated inhibition of oIPSC in VP slices containing no NAc
neurons, D2R-OENAcInd mice displayed robust viral-mediated
D2R immunofluorescence in D2-MSN terminal fields innervating
the VP, further supporting a presynaptic role for D2Rs. In this
respect, ultrastructural studies in VP have shown that most D2R-
























































































































Fig. 6 DREADD-mediated silencing of D2-MSN terminals in the VP enhances motivation. a Schematic illustrating oIPSC recording from VP neurons in slice
following CNO (10 µM) treatment and blue-light stimulation of terminal fields from NAc MSNs co-expressing ChR2 and hM4Di. b Representative average
oIPSC traces following 50-ms light stimulation under basal conditions (black) and after CNO application (dark red). c CNO significantly reduced oIPSC
amplitude from baseline (14.5 ± 3.1 from 43.6 ± 8.3 pA; **p < 0.005, paired Student’s t-test, n= 9 (6) cells). d Drd2-Cremice were injected hM4Di-mCherry
AAV into the NAc, and a bilateral microinfusion cannula guide was implanted. Four weeks after surgery, an internal cannula was briefly inserted into the
guide to deliver CNO (1 mM, 0.3 µl/side) or saline to the caudal VP prior to PR testing. All 16 mice received both treatments on different days in
counterbalanced fashion. e Representative fluorescent Nissl stain (green) showing the location of bilateral microinfusion cannula tracks (yellow dotted
lines) relative to hM4Di-mCherry immunofluorescent terminal fields (red) in the caudal aspect of the VP. Inset, coronal atlas plane (+0.02mm relative to
Bregma) from which image was acquired. f, g Significant enhancing effect of CNO microinfusion on session duration plotted as a survival function or as
total session time (n= 16 mice/condition). h, i Lever presses and breakpoint were significantly increased after CNO (n= 16 mice/condition). j Press rate as
a function of ratio requirement was not altered by CNO. Error bars= s.e.m.
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dopamine modulation of VP activity has been consistently
reported, the role of presynaptic D2R function in the VP is less
well understood, likely due to a lack of cell-type specific
approaches56. Here, we provide new evidence linking D2Rs spe-
cifically found in afferent D2-MSN terminals to VP neuron
activity.
A recent study reported that optogenetic inhibition of the NAc
indirect pathway led to a decrease in progressive ratio perfor-
mance67, whereas here decreasing indirect pathway function
enhances motivation. However, there are important differences
between both studies in the site of inhibition (unilateral versus
bilateral inhibition), in the time window of inhibition (10 s vs. the
entire session), and in the design of the task (inhibition of activity
during a cue that signals the onset of the trial versus no explicit
cue). It is therefore possible that the indirect pathway may have
opposite functions regarding motivation depending on whether it
is active during a cue signaling later reward or during the sus-
tained process of working in the form of lever pressing. Moreover,
unlike neuronal inhibition during a discrete time point in the
task67, our approach is designed to turn up the gain for endo-
genously released dopamine acting on indirect pathway D2Rs.
Higher D2R levels in ventral striatum have been linked to
higher trait motivation in ADHD and better treatment outcomes
for drug abusers10,68. However, it has been unclear how altered
D2R function affects ventral striatal circuitry and behavior. Here
we show that selective D2R upregulation in indirect pathway
MSNs is sufficient to invigorate motivated behavior by decreasing
indirect pathway output. While our cell-selective D2R upregula-
tion in the mouse is not intended to model a specific disorder, it
has helped to provide mechanistic insight into the role of NAc
D2Rs in motivation. This should have clinical relevance since
D2R binding is altered in brain disorders with altered motiva-
tion9–15. Our results suggest that D2R-based or related strategies
for decreasing ventral striatopallidal transmission may have the
potential to advance therapies for reversing motivational deficits
across multiple brain disorders. In particular, the adenosine A2A
receptor (A2AR) has been proposed as a promising therapeutic
target for the motivational symptoms of depression69. A2ARs are
co-expressed with D2Rs in indirect pathway MSNs and are
thought to oppose D2R function70. Indeed, A2AR antagonism
within the NAc has been shown to enhance motivated behavior in
rats69,71. Our results suggest that the mechanisms by which A2AR
antagonists increase motivation may involve increased D2R
function in D2-MSNs, and thus a weakening of indirect pathway
output.
Methods
Mice. Adult male and female Drd2-Cre (ER44; GENSAT), Drd2-Cre/D1-tdTomato
(B6.Cg-Tg(Drd1a-tdTomato)6Calak/J; Jackson); ChAT-Cre (GM60; GENSAT)
backcrossed onto C57BL/6 J background were used in experiments. Mice were
housed 3–5 per cage for most experiments or individually for Ca2+ imaging
experiments, on a 12 h light/dark cycle. All experiments were conducted in the light
cycle. All experimental procedures were conducted following NIH guidelines and
were approved by Institutional Animal Care and Use Committees by Columbia
University and New York State Psychiatric Institute.
Surgical procedures. Mice (≥8 weeks old) were bilaterally injected with a pre-
viously characterized Cre-dependent double-inverted open reading frame (DIO)
adenoassociated viruses (AAVs) encoding D2R-ires-Venus19, EGFP, ChR2-EYFP,
hM3Dq-mCherry, or hM4Di-mCherry (UNC Vector Core, Chapel Hill, NC) into
the nucleus accumbens (NAc) using stereotactic Bregma-based coordinates:73 AP,
+ 1.70 mm; ML, ± 1.20 mm; DV, –4.1 mm (from dura). Groups of mice used for
experiments were first assigned their AAV-genotype in a counterbalanced fashion
that accounted for sex, age, home cage origin. For cannula-guided microinfusion
experiments, mice were implanted in caudal VP with a bilateral guide cannula (AP,
+ 0.12 mm; ML, ± 1.5 mm; DV, −2.5 mm (from dura) at the time of AAV surgery.
On test days, following brief restraint of the mice, dummy cannulae were removed
and internal cannulae (33 G) with a 2 mm projection were inserted into guide to
achieve a final depth of –4.5 mm. The guide cannulae (26 G; Plastics One, Roanoke,
VA) were anchored with machine microscrews and fixed in place with dental
cement. Dummy cannulae were placed into the guide and protected with a dust
cap. For Ca2+ imaging of NAc, a 0.5 mm craniotomy was made at the following
coordinates: AP:+ 1.7 mm, ML:+ 1.2 mm (right side). Brain tissue was then
carefully aspirated by lowering aspiration needle at a rate 0.1 mm/min until a depth
of –2.4 mm (from skull surface). After aspiration, a 1:1 mix of AAV-DIO-mCherry
(Addgene) or AAV-DIO-D2-IRES-mCherry AAV and a Cre-OFF AAV-FAS-
GCaMP6f (constructed in-house using pAAV-Ef1a-FAS-hChR2(H134R)-
mCherry-WPRE-pA from Bernardo Sabatini and produced at Vector Biolabs) was
bilaterally injected (AP:+ 1.7 mm, ML: ± 1.2 mm, DV: −4.2, −4.1, and −4.0 mm;
0.22 µl at each depth). A 0.5 mm diameter gradient index (GRIN) lens affixed to an
imaging cannula (Doric Lenses, Inc.) was then carefully lowered through same
skull opening to D/V: −4.1 mm. Lens cannula was anchored with machine
microscrews and fixed in place with dental cement. Mice were imaged 5–6 weeks
after cannula implantation.
Operant apparatus. Eight operant chambers (model Env-307w; Med-Associates,
St. Albans, VT) equipped with liquid dippers were used. Each chamber was located
in a light- and sound-attenuating cabinet equipped with an exhaust fan, which
provided 72-dB background white noise in the chamber. The dimensions of the
experimental chamber interior were 22 × 18 × 13 cm, with flooring consisting of
metal rods placed 0.87 cm apart. A feeder trough was centered on one wall of the
chamber. An infrared photocell detector was used to record head entries into the
trough. Raising of the dipper inside the trough delivered a drop of evaporated milk
reward. A retractable lever was mounted on the same wall as the feeder trough, 5
cm away. A house light located on wall opposite to trough illuminated the chamber
throughout all sessions.
Dipper and lever press training. Four weeks after AAV surgery, mice underwent
operant training. Mice were weighed daily and food-restricted to 85–90% of
baseline weight; water was available ad libitum. In the first training session, 20
dipper presentations were separated by a variable inter-trial interval (ITI) and
ended after 20 rewards were earned or after 30 min had elapsed, whichever
occurred first. Criterion consisted of the mouse making head entries during 20
dipper presentations in one session. In the second training session, criterion was
achieved when mice made head entries during 30 of 30 dipper presentations. For
lever press training, lever presses were reinforced on a continuous reinforcement
(CRF) schedule. Levers were retracted after each reinforcer and were presented
again after a variable ITI (average 30 s). The reward consisted of raising the dipper
for 5 s. The session ended when the mouse earned 60 reinforcements, or one hour
elapsed, whichever occurred first. Sessions were repeated daily until mice achieved
60 reinforcements.
Fixed interval (FI) training. In FI training, lever presses were reinforced until after
a fixed interval (timed relative to the lever extension) had elapsed. Each reinfor-
cement was followed by a variable inter-trial interval (average 30 s) during which
the lever remained retracted, and then a new trial started, signaled by lever
extension. Mice began with FI-4 s session and proceeded successively to longer
interval sessions after earning ≥ 30 rewards in each session. The FI durations were
4, 8, 12, 16, and 24 s.
Progressive ratio (PR) and fixed ratio (FR) tasks. Mice underwent operant
training 4 weeks after surgery followed by PR. In PR, a reward was obtained after
the mice made the required number of lever presses. The criterion was set at two
lever presses for the first trial and the requirement doubled with each successive
trial. The session ended after 2 h or after 3 min had elapsed without a lever press.
Breakpoint was defined as the last criterion successfully completed. Mean values
from 3 PR sessions were analyzed. For hM4Di experiments, CNO (0.3 µl, 1 mM in
saline) or saline was delivered bilaterally to VP via cannula-based microinfusions
using a Hamilton syringe and a microdrive motor at a rate of 0.05 µl/min. At the
end of each infusion, the internal cannula was left in place for 15 min to ensure
diffusion, and mice were tested on PR task 5 min after removing the internal and
replacing the dummy. Each mouse received one infusion of saline and one of CNO,
3 days apart. Investigators were blind to genotype of mice during the experiment,
and the order of the infusions was counterbalanced between groups, matched for
age and sex. Mice had two intervening RR5 sessions in the days between each PR
test.
Concurrent choice task. For this task, we used random ratio (RR) schedules,
which involve a constant probability of reinforcement for each lever press and
assess effort in instrumental responding18. The mice were first trained for 3 days in
30 min RR5 sessions. Animals were then tested in concurrent RR/choice procedure.
This task consisted of having 8–12 g of lab chow freely available in a dish in the
operant chamber while the mouse performed the RR schedule. Increasing ratios
with and without chow were used (RR5, RR10, RR20, RR40, RR80, RR120). One
animal was excluded from the data analysis because of lever pressing extinction.
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Slice preparation and whole-cell patch clamp recording. Four weeks after
surgery, brains were harvested into ice-cold, oxygenated ACSF containing (in mM):
1.25 NaH2PO4, 2.5 KCl, 10 glucose, 26.2 NaHCO3, 126 NaCl, 2 CaCl2 and 2 MgCl2
(pH 7.4, 300–310 mOsm). Coronal striatal slices (300 μm) were cut on a vibratome
in ice-cold, oxygenated ACSF and incubated at 32 °C for 30 min followed by 1 h at
room temperature before recording. Voltage- and current-clamp whole-cell
recordings were performed using standard techniques at room temperature.
Electrodes were pulled from 1.5 mm borosilicate-glass pipettes on a P-97 puller
(Sutter Instruments). Electrode resistance was ~4–6MΩ when filled with internal
solution consisting of (in mM): 130 K+-Gluconate, 5 NaCl, 10 HEPES, 0.5 EGTA, 2
Mg+-ATP, and 0.3 Na+-GTP (pH 7.3, 280 mOsm). Whole-cell patch-clamp
recordings were obtained with a Multiclamp 700B amplifier, digitized at 10 kHz
using a Digidata 1440 A acquisition system with Clampex 10, and analyzed with
pClamp 10 (Molecular Devices). Only cells that maintained a stable access resis-
tance (<30MΩ) throughout the entire recording were analyzed. GFP/Venus or
tdTomato positive MSNs within the NAc core were identified under IR-DIC optics
and epifluorescence microscopy. Current–voltage and input–output (spike fre-
quency) curves were obtained from injecting 500 ms currents ranging from −150
to +340 pA in 10 pA steps. Spiking frequency (Hz) was determined from the initial
pair of action potentials72. mIPSCs were isolated by adding TTX (1 µM), D-AP5
(50 µM), and CNQX (20 µM) in ACSF while recording at a holding potential of
−80 mV and measured over a period of 6 min using Synaptosoft Mini Analysis
software. To enhance detection of mIPSCs, we used high Cl− internal solution,
consisting of (in mM): 136.5 KCl, 10 HEPES, 0.5 EGTA, 2 Mg+-ATP, and
0.3 Na+-GTP (pH 7.3, 280 mOsm). Light-evoked IPSC experiments were done at
RT at –80mV in the presence of D-AP5 (50 µM) and CNQX (20 µM). oIPSCs were
evoked with five 1-ms or 50-ms light pulses (470 nm, 1 Hz, 2.3 mW) using field
illumination through a ×40 objective with a PE-100 CoolLED illumination system
(Olympus). High Cl− internal solution, as shown above, was used to enhance
detection of oIPSCs. We blocked oIPSCs using 10 µM bicuculline. Peak amplitudes
of oIPSCs were measured from averages of five individual traces. Slices were treated
for 5 min with quinpirole hydrochloride (1 µM), sulpiride (1 µM) or clozapine N-
oxide (10 µM). To measure asynchronous IPSCs, recordings were conducted at 32 °
C in extracellular solution containing 2 mM Sr2+ (0 mM Ca2+), D-AP5 (50 µM)
and CNQX (20 µM), while holding at –70 mV. Internal solution was as for mIPSC
solution with substitution of KCl with 136.5 mM CsCl and the addition of 2 mM
QX-314 hydrobromide. Ten trials using a 5-ms blue light pulse (0.6 Hz) were used
to activate ChR2-positive terminals and generate asIPSCs. Detection of asIPSCs
occurred within the 50–500 ms period after the stimulus47. asIPSCs were detected if
greater than 2 S.D. above noise using Synaptosoft MiniAnalysis software, and the
amplitude of each event was measured from a local baseline 5 ms before the start of
peak to avoid decaying transient artifacts associated with residual synchronous
release46.
In vivo single unit recordings. Mice anesthetized with chloral hydrate were
implanted with a stimulating electrode (Tungsten concentric, Microprobes) for
electrical stimulation of the mPFC (AP+ 1.9, ML ± 0.3, DV −2.0). A glass elec-
trode (impedance 12–14MΩ) filled with 2 M NaCl was lowered into the VP (AP
−0.1, ML ± 1.5, DV −4.0) using a hydraulic microdrive to detect spontaneously
active pallidal neurons. From this starting point, the VP was sampled in four
locations 0.15 mm apart and arranged in a 2 × 2 spaced grid. The starting locations
were counterbalanced across animals and groups. Pallidal neurons were identified
using a combination of stereotaxic position and narrow action potential width (<1
ms). After 2–3 min of stable recording, electrical stimulation (50 pulses, 0.2 ms
pulse width, 0.5 Hz) was applied at 0.25, 0.5, 0.75, and 1.0 mA current intensities.
Neuronal activity was amplified and filtered (1000 × gain, 100–10 KHz band pass)
and fed to an audio monitor and to a computer interface with custom-designed
acquisition and analysis software (Neuroscope). Peri-stimulus time histograms
(PSTHs) were obtained by sampling spike frequency with 5 ms bins 200 ms before,
during and 200 ms after electrical stimulation. Spike frequencies in the PSTHs were
expressed as Z scores expressed as a function of baseline firing during the 200 ms
preceding electrical stimulation. Average firing rate over the first 75 ms following
electrical stimulation was then compared between the 2 groups.
In vivo calcium imaging. For Ca2+ imaging experiments, mice were habituated to
a dummy microscope and cables during final phases of FI training. Prior to PR test,
a Doric Lenses snap-in microscope was attached to the imaging cannula under
brief isoflurane anesthesia. Ten minutes after full recovery, mice were placed in
operant chamber to begin PR session. Image acquisition was done at 10 Hz, trig-
gered by presentation of the 3rd reward (completion of ratio 8) and lasting for 5
consecutive minutes, and was conducted over 2 daily PR sessions. This period was
chosen because it generally showed the highest press rates, generated more than 1
reward, and showed no difference in responding between groups. FR5 sessions, in
which mice must make 5 presses to earn a reward, were conducted similarly over 5
min, but with image acquisition starting at session onset.
Image stacks collected using the microendoscope imaging system were
registered using Doric Neuroscience Studio Image Analysis software. Each stack
was then imported into the CNMF-E framework as previously described50. CNMF-
E was used to locate neurons and extract raw Ca2+ fluorescence values over time.
Neural Ca2+ transients were defined as events whose ΔF/F peak amplitudes were
greater than 1 standard deviation above the baseline fluorescence. Custom
MATLAB functions and scripts were used to import and analyze MedPC
(MedAssociates) behavioral data corresponding to each of the fluorescence traces.
Histology. Mice were transcardially perfused with ice-cold 4% paraformaldehyde
(Sigma, St. Louis, MO) in PBS under deep anesthesia. Brains were harvested, post-
fixed overnight and washed in PBS. Free-floating 30-µm coronal sections were
obtained using a Leica VT2000 vibratome (Richmond, VA). After incubation in
blocking solution (10% fetal bovine serum, 0.5% bovine serum albumin in 0.5%
TBS-Triton X-100) for 1 h at room temperature, sections were labeled overnight at
4 °C with primary antibodies against GFP/mVenus/GCaMP6f (chicken; 1:1000;
AB13970 Abcam, Cambridge, MA); D2R (rabbit; 1:500; in-house); Cre (rabbit,
1:2000; in-house74); and DsRed (rabbit; 1:250; 632496, Clontech, Mountain View,
CA) to label mCherry. Sections were incubated with fluorescent secondary anti-
bodies for 1 h at RT followed by, in some cases, incubation in Neurotrace® green
fluorescent Nissl stain according to manufacturer’s protocol (Life Technologies,
Grand Island, NY). Sections were then mounted on slides and coverslipped with
Vectashield containing DAPI (Vector, Burlingame, CA). Digital images were
acquired using a Nikon epifluorescence microscope, or with a Leica SP8 scanning
confocal microscope, and processed with NIH Image J and Adobe Photoshop
software.
Data analysis. Sample sizes were determined by performing statistical power
analyses based on effect sizes observed in preliminary data or on similar work in
the literature. Statistical analyses were performed using Graphpad Prism 5.01. Data
are expressed as mean ± SEM. Paired and unpaired two-tailed Student’s t-tests were
used to compare 2-group data, as appropriate. Multiple comparisons were eval-
uated by one-way or two-way ANOVA and Bonferroni’s post hoc test, when
appropriate. Log-rank tests were used to analyze survival curves. A p-value of <0.05
was considered statistically significant. Behavioral and electrophysiological findings
were successfully replicated with mice from different litters, ages, or sexes, and in
several instances, across independent cohorts or related mouse strains. In addition,
evoked electrophysiology responses were replicated using different stimulus
intensities in vitro and in vivo, and data was collected from several animals.
Code availability. Custom code used to generate results that are reported in the
paper will be made available upon reasonable request.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
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